Premium Market Research: Molluscum Contagiosum Market Share In Depth Analysis

Molluscum Contagiosum Market: Introduction

  • Molluscum contagiosum is a skin infection caused by a poxvirus (molluscum contagiosum virus), which is usually benign. Appearance of lesions anywhere on the body is a characteristic of mild skin disease. These lesions are Mollusca and are small, raised, and usually white, pink, or flesh-colored with a pit at the center. The size of the Mollusca ranges from 2 mm to 5 mm in diameter.
  • The lesions primarily appear on the face, neck, arms, legs, abdomen, and genital area. These are not found on hands or soles of the feet. However, the virus remains in the top layer of skin and is not circulated throughout the body. It can remain dormant in the body for long periods and could reoccur.
  • The virus spreads from direct person-to-person physical contact and through contaminated fomites. It could spread through sharing of baths, swimming pools, saunas, or other wet environments.
  • Secondary infection caused by bacteria is the major complication of the virus. It is a significant problem among immunocompromised patients, such as patients with HIV/AIDS.

View Report :  https://www.transparencymarketresearch.com/molluscum-contagiosum-market.html

Key Drivers of Global Molluscum Contagiosum Market

  • Increase in number of approvals for new drugs from regulatory authorities such as the Food and Drug Administration (FDA), rise in emphasis on research & development, and promising drugs under pipeline are the various factors expected to drive the global molluscum contagiosum market
  • In December 2019, the FDA accepted Verrica Pharmaceuticals’ New Drug Application filing for cantharidin 0.7% topical solution. The solution is indicated for the treatment of molluscum contagiosum. The company is the first to receive such approval and plans to market the drug if approved by the agency.

Topical Therapies Segment to Account for Major Share of Global Market

  • In terms of therapy, the global molluscum contagiosum market can be classified into cryotherapy, curettage, immune-modulating therapies, topical therapies, and others
  • The topical therapies segment is anticipated to dominate the global market during the forecast period, owing to ongoing R&D activities by prominent players and increase in awareness about topical therapies for molluscum contagiosum among patients

Get PDF Sample Copy of Report: (Including TOC, List of Tables & Figures, Chart) :   https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=76803

Skin Clinics to be Highly Attractive Segment

  • Based on end-user, the global molluscum contagiosum market can be categorized into hospitals, skin clinics, and others
  • The skin clinics segment is expected to account for significant share of the global molluscum contagiosum market by 2027. High prevalence of the disease, especially in countries in Europe such as the U.K., Germany, and Spain, is projected to boost the growth of the segment.

North America to Dominate Global Molluscum Contagiosum Market

  • In terms of region, the global molluscum contagiosum market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
  • North America is projected to dominate the global molluscum contagiosum market during the forecast period. Strengthening of R&D by prominent players in the U.S., high adoption of topical medications for various skin problems, and rise in expenditure on new drug development are the various factors projected to propel the market in North America
  • In March 2018, CVS Pharmacy selected ZymaDerm, a topical treatment for molluscum contagiosum, for sale at its retail stores. It is a fast-acting, painless treatment for the disease and is widely accepted in the U.S.

REQUEST FOR COVID19 IMPACT ANALYSIS – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=76803

Key Players Operating in Global Molluscum Contagiosum Market

The global molluscum contagiosum market is highly fragmented, with a large number of domestic players accounting for majority share.  Key players operating in the global molluscum contagiosum market are:

  • Verrica Pharmaceuticals
  • Novan, Inc.

Global Molluscum Contagiosum Market: Research Scope

Global Molluscum Contagiosum Market, by Therapy

  • Cryotherapy
  • Curettage
  • Immune-modulating Therapies
  • Topical Therapies
  • Others

Global Molluscum Contagiosum Market, by End-user

  • Hospitals
  • Skin Clinics
  • Others

Global Molluscum Contagiosum Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

More Trending Reports by Transparency Market Research – 1. https://www.prnewswire.com/news-releases/limitations-of-in-house-medical-research-promises-growth-for-contract-research-organization-service-market-transparency-market-research-301002598.html

2. https://www.biospace.com/article/angioplasty-balloons-and-stents-market-introduction/

Previous post Top Companies: Low Endotoxin Gelatin Market Challenges and Opportunities 2018 – 2026
Next post New Market Research: X-linked Hypophosphatemia (XLH) Market News Break Down by Driving Factors and Forecast 2027